Trial Details

COMPLETED
Basic Information
Clinical ID c1425
Identifier NCT01124149
Trial Title Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: MMX mesalamine/ mesalazine
Participant Information
Sponsor Shire
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2010-06-29
Primary Completion Date 2012-12-07
Completion Date 2012-12-07